NasdaqGS - Delayed Quote • USD
ICON Public Limited Company (ICLR)
At close: 4:00 PM EDT
After hours: 4:06 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 15 | 15 | 16 | 16 |
| Avg. Estimate | 3.41 | 3.61 | 14.94 | 17.07 |
| Low Estimate | 3.12 | 3.49 | 14.65 | 15.55 |
| High Estimate | 3.52 | 3.69 | 15.11 | 17.4 |
| Year Ago EPS | 2.9 | 3.11 | 12.79 | 14.94 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 14 | 14 | 16 | 16 |
| Avg. Estimate | 2.09B | 2.14B | 8.63B | 9.27B |
| Low Estimate | 2.07B | 2.11B | 8.5B | 9.01B |
| High Estimate | 2.12B | 2.19B | 8.75B | 9.43B |
| Year Ago Sales | 1.98B | -- | 8.12B | 8.63B |
| Sales Growth (year/est) | 5.40% | -- | 6.30% | 7.40% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 2.87 | 3.08 | 3.28 | 3.44 |
| EPS Actual | 2.9 | 3.11 | 3.3 | 3.46 |
| Difference | 0.03 | 0.03 | 0.02 | 0.02 |
| Surprise % | 1.00% | 1.00% | 0.60% | 0.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 3.41 | 3.61 | 14.94 | 17.07 |
| 7 Days Ago | 3.44 | 3.62 | 14.94 | 17.06 |
| 30 Days Ago | 3.44 | 3.61 | 14.94 | 17.05 |
| 60 Days Ago | 3.47 | 3.63 | 14.91 | 17.09 |
| 90 Days Ago | 3.47 | 3.64 | 14.88 | 17.05 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | 2 | 1 | 3 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | ICLR | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 17.60% | -- | -- | 1.60% |
| Next Qtr. | 16.10% | -- | -- | 10.50% |
| Current Year | 16.80% | -- | -- | 5.20% |
| Next Year | 14.30% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 14.23% | -- | -- | 11.22% |
| Past 5 Years (per annum) | 19.45% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | Baird: Outperform to Outperform | 4/4/2024 |
| Reiterates | Mizuho: Buy to Buy | 4/4/2024 |
| Maintains | Evercore ISI Group: Outperform to Outperform | 2/23/2024 |
| Maintains | Mizuho: Buy to Buy | 2/23/2024 |
| Maintains | Barclays: Overweight to Overweight | 2/23/2024 |
| Maintains | Truist Securities: Buy to Buy | 2/23/2024 |
Related Tickers
IQV IQVIA Holdings Inc.
228.09
+0.40%
CRL Charles River Laboratories International, Inc.
226.78
-0.34%
MTD Mettler-Toledo International Inc.
1,188.54
-0.34%
MEDP Medpace Holdings, Inc.
372.00
-0.62%
QGEN Qiagen N.V.
40.00
+1.34%
IDXX IDEXX Laboratories, Inc.
476.35
-0.30%
WAT Waters Corporation
296.10
+0.64%
LH Laboratory Corporation of America Holdings
201.48
+1.02%
A Agilent Technologies, Inc.
132.73
+0.22%
SHC Sotera Health Company
10.95
+0.46%